HCN exists to help optimise health innovation value chains by connecting hard sciences, industry, clinical practice and patient advocacy. HCN is in its 3rd iteration. It started as an INTERREG IIIC network operation in 2005, became a UK registered (non-profit) company in 2008 and is now a Stichting registered with the Amsterdam Chamber of Commerce.
Our approach can be summarised as helping to close the gap between what we know and what we need to do by generating practical ‘how-to’ knowledge in all our workstreams. This is shaped by 5 guiding principles to create value over time: connectivity, pluralism, innovation, resilience and added value. To achieve this, we have worked with people at all levels from a government minister to community groups, from comprehensive cancer centres to SME owners and from senior decision-makers to students.
HCN has 3 activity streams:
EU FUNDED PROJECTS
HCN is, and has been, a partner/lead partner in several EU funded projects. HCN has a particular focus on optimising value chains for health and innovation (IA projects – INNOLABS, Cross4Health, a CSA project – DanuBalt, a health programme project – BenchCan) and securing added social and economic value from health investment at national and sub-national levels (ESI Funds for Health, HealthEquity-2020, EUREGIO III, HCN in its INTERREG IIIC phase).
EUREGIO III was our first project as a lead partner and informed the EU Council Conclusions (June 2011) Towards modern, responsive and sustainable health systems and that cited as a key reference in the report by HSPA (2017) Blocks: tools and methodologies to assess integrated care in Europe, EU, Luxembourg.
NOVEL INTERVENTIONS ALONG THE CANCER CARE CONTINUUM
We are commissioned to co-write proposals to secure major research funding (H2020, CRUK Grand Challenge, EU Health Programme, INTERREG etc.) for leading consortia who want to bring hard science, clinical practice and patient advocacy together in improving patient outcomes in cancer care. Since 2014, we have helped secure €23m for Storming Cancer (led by UCSF), €17.5m for PRECISION (led by NKI) and €10m for COLOSYS (led by NTNU), INTENT (led by IRCCS-IOV), B-CAST (led by NKI) and BenchCan led by OECI.
EXTERNAL EXPERTISE AND ADVICE
This is done in several ways asked (i) to review proposals prior to submission e.g. research infrastructure, high-performance computing to improve personalised medicine, or being (ii) an advisor (WHO/P4H Network 1st Expert Consultation on private sector participation in health financing in Asia, University of Fudan, Shanghai, October 2019; WHO EURO, In Demand, RegHealth-R), (iii) an external evaluator for H2020 ‘Health & Wellbeing’ and the EU Health Programmes, (v) a pre-submission proposal reviewer (ELIXIR, CORBEL), (v) an Advisory Board member for EU funded projects e.g. inDemand, RegHealth-RI (vi) external evaluator for the EIT Health Bridgehead Programme (vii) commissioned to write policy and practice briefings e.g. for WHO and EU.
Previously (vi) an external expert for DG Regio for implementation of Cohesion Policy 2014-2020 (vii) technical advisor for WHO/EURO Verona Initiative 1998-2000.
Founder and Managing Director of the Dutch-registered Stichting HCN (2019+). Founder and Sole Director of UK registered HCN (2008-2019).
Professor at Institute of Nursing and Health Sciences, Universitetet I Sørøst-Norge
Previously: Special Professor of Health & Public Policy, University of Nottingham; Lay Court member, Edinburgh Napier University; MD of CCL Associates; Director of Research & Evaluation, Health Education Board for Scotland; Visiting Professor, University of York
Sociologist, Project Manager for BENCH-CAN and previously for EUREGIO III project
PhD student for Active and Healthy Ageing, Eötvös Loránd University of Science, Budapest
Owner Scientific Network Management SL (Spain registered)
Life Science Research and Innovation Funding - Operations Management - Business Development
Expert in Grant Writing - Assessment - Training - Project Management
After posts in management consultancy and industry, Mr Stephen Wright joined the European Investment Bank to work on various economic areas – energy, industry, transport, waste management, economic development – before establishing and running the Bank’s policy and project appraisal in the health and education sector. He ended his career in the Bank as a Director. Now he is a freelance consultant in health policies, macroeconomics, social investment, and health finance and investment, for EU Member States, European Commission, EIB, World Bank and WHO. Mr Wright has co-edited a number of books. He publishes and presents frequently on these topics.
Visiting Director of HTA and Market Access
Director of Organisational Innovation & Management, BIOEF
President of HTAi
Vice Chair of Euroscan
Associate Professor at the School of Nursing of Osakidetza Basque Health Service
PhD student for integrated urban development for CHO, University of Science of Pécs, Hungary
External evaluation of projects under EU Health Programme, evaluation of national policies in nutrition, investment in health promotion
Founder and Manager of „funding4health“ Germany: Health technology, innovation management, internationalisation, transnational cluster and ecosystems collaboration
Director of Innovation and Technology of „SIVSA MeQ“ Spain: International Turn Key Solutions in Healthcare
External expert of EU Health Innovation Programmes
In house consulting of different cluster organisations and ecosystems in Latin America & The Caribbean
Previously: Global Marketing, Sales and Financing Manager in the medical technology industry (Europe, Middle East Africa, Americas).
HCN also has a network of colleagues across the EU that we involve as in-house consultants when needed.